Takeda Pharmaceutical Company Limited【JP:4502】Balance sheet
Market cap
¥8.08T
P/E ratio
52.3x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 210,200 | 242,072 | 88,850 | 174,395 | 702,093 | 637,614 | 966,222 | 849,695 | 533,530 | 457,800 | 385,113 |
| Marketable securities, current | - | 105,000 | - | - | 80,646 | 23,276 | 15,822 | 36,598 | 25,305 | 20,174 | 15,089 | 20,476 |
| Inventories | - | 57,006 | 57,950 | 46,265 | 37,666 | 986,744 | 759,599 | 753,881 | 853,167 | 986,457 | 1,209,869 | 1,217,349 |
| Total current assets | - | 814,411 | 781,634 | 687,081 | 597,599 | 3,050,658 | 2,469,432 | 2,712,893 | 2,593,642 | 2,397,956 | 2,558,580 | 2,521,192 |
| Property, plant and equipment, net | - | 253,833 | 245,377 | 233,684 | 215,213 | 1,316,531 | 1,386,370 | 1,453,917 | 1,582,800 | 1,691,229 | 1,989,777 | 1,968,209 |
| Marketable securities, non-current | - | 117,476 | 99,417 | 116,343 | 96,417 | 192,241 | 262,121 | 235,882 | 233,554 | 279,683 | 340,777 | 351,124 |
| Total non-current assets | - | 1,776,773 | 1,917,821 | 2,405,988 | 2,359,302 | 10,821,664 | 10,351,662 | 10,199,400 | 10,584,376 | 11,559,794 | 12,550,212 | 11,727,152 |
| Total assets | - | 2,591,184 | 2,699,455 | 3,093,070 | 4,106,463 | 13,872,322 | 12,821,094 | 12,912,293 | 13,178,018 | 13,957,750 | 15,108,792 | 14,248,344 |
| Short-term debt | - | - | - | 452,844 | 78,549 | 47,340 | 95,706 | 248,053 | 196,071 | 185,537 | 143,421 | 219,120 |
| Long-term debt, current | - | 30,000 | - | 80,000 | 18 | 984,946 | 586,817 | 22,153 | 203,993 | 339,600 | 367,251 | 548,939 |
| Total current liabilities | - | 478,099 | 529,032 | 901,241 | 354,039 | 2,510,931 | 2,175,898 | 1,773,176 | 2,145,730 | 2,481,940 | 2,313,103 | 2,506,521 |
| Long-term debt, non-current | - | 210,000 | 360,000 | 480,000 | 1,076,867 | 5,001,791 | 4,905,616 | 5,130,895 | 4,610,361 | 4,577,010 | 5,164,334 | 4,517,226 |
| Total non-current liabilities | - | 635,231 | 598,224 | 661,381 | 1,040,884 | 6,197,803 | 5,917,710 | 5,961,940 | 5,348,764 | 5,121,138 | 5,521,684 | 4,805,844 |
| Total liabilities | - | 1,113,330 | 1,127,256 | 1,562,622 | 2,089,054 | 8,708,734 | 8,093,608 | 7,735,116 | 7,494,495 | 7,603,078 | 7,834,788 | 7,312,365 |
| Common stock and paid-in capital | - | 114,186 | 115,630 | 116,503 | 310,577 | 6,567,082 | 6,670,750 | 6,678,953 | 6,729,675 | 6,751,933 | 6,786,203 | 6,874,845 |
| Retained earnings | - | 1,317,080 | 1,437,921 | 1,404,415 | 1,449,122 | 1,569,365 | 1,369,972 | 1,509,906 | 1,479,716 | 1,541,146 | 1,391,203 | 1,187,586 |
| Stockholders' equity | 1,584,309 | 1,477,854 | 1,572,199 | 1,530,447 | 1,561,978 | 5,163,588 | 4,727,486 | 5,177,177 | 5,683,523 | 6,354,672 | 7,274,005 | 6,935,979 |